Epidemiological analysis of Group A streptococcus infection diseases among children in Beijing, China under COVID-19 pandemic

BMC Pediatr. 2023 Feb 13;23(1):76. doi: 10.1186/s12887-023-03885-7.

Abstract

Background: Group A streptococcus is human-restricted gram-positive pathogen, responsible for various clinical presentations from mild epidermis infections to life threatened invasive diseases. Under COVID-19 pandemic,. the characteristics of the epidemic strains of GAS could be different.

Purpose: To investigate epidemiological and molecular features of isolates from GAS infections among children in Beijing, China between January 2020 and December 2021. Antimicrobial susceptibility profiling was performed based on Cinical Laboratory Sandards Institute. Distribution of macrolide-resistance genes, emm types, and superantigens was examined by polymerase chain reaction.

Results: 114 GAS isolates were collected which were frequent resistance against erythromycin (94.74%), followed by clindamycin (92.98%), tetracycline (87.72%). Emm12 (46.49%), emm1 (25.44%) were dominant emm types. Distribution of ermB, ermA, and mefA gene was 93.85%, 2.63%, and 14.04%, respectively. Frequent superantigenes identified were smeZ (97.39%), speG (95.65%), and speC (92.17%). Emm1 strains possessed smeZ, ssa, and speC, while emm12 possessed smeZ, ssa, speG, and speC. Erythromycin resistance was predominantly mediated by ermB. Scarlet fever strains harbored smeZ (98.81%), speC (94.05%). Impetigo strains harbored smeZ (88.98%), ssa (88.89%), and speC (88.89%). Psoriasis strains harbored smeZ (100%).

Conclusions: Under COVID-19 pandemic, our collections of GAS infection cutaneous diseases decreased dramatically. Epidemiological analysis of GAS infections among children during COVID-19 pandemic was not significantly different from our previous study. There was a correlation among emm, superantigen gene and disease manifestations. Long-term surveillance and investigation of emm types and superantigens of GAS prevalence are imperative.

Keywords: Antimicrobial resistance; COVID-19 pandemic; Children; China; Emm type; Group A streptococcus; Scarlet fever; Superantigen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Antigens, Bacterial / genetics
  • Beijing / epidemiology
  • COVID-19* / epidemiology
  • Child
  • China / epidemiology
  • Erythromycin / pharmacology
  • Erythromycin / therapeutic use
  • Humans
  • Microbial Sensitivity Tests
  • Streptococcal Infections* / epidemiology
  • Streptococcus pyogenes
  • Superantigens / genetics

Substances

  • Antigens, Bacterial
  • Anti-Bacterial Agents
  • Erythromycin
  • Superantigens